Docetaxel (Taxotere) in hormone-refractory prostate cancer

被引：0
|
作者：
Petrylak, DP [1 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Columbia Presbyterian Med Ctr, Div Med Oncol, New York, NY 10032 USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 29
页数：6
相关论文
共 50 条
  • [1] Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: Preliminary results
    Picus, J
    Schultz, M
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 14 - 18
  • [2] Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer
    Oh, WK
    Kantoff, PW
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 49 - 54
  • [3] Docetaxel (Taxotere) in hormone-refractory prostate cancer: A new addition to the physicians' toolbag
    Vogelzang, NJ
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 1 - 2
  • [4] Docetaxel and exisulind in hormone-refractory prostate cancer
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 56 - 61
  • [5] Docetaxel in hormone-refractory metastatic prostate cancer
    Oh, WK
    [J]. DRUGS, 2005, 65 (16) : 2296 - 2297
  • [6] Docetaxel for hormone-refractory prostate cancer Reply
    Damber, Jan-Erik
    Aus, Gunnar
    [J]. LANCET, 2008, 372 (9648): : 1461 - 1462
  • [7] Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer
    Petrylak, DP
    Macarthur, R
    O'Connor, J
    Shelton, G
    Weitzman, A
    Judge, T
    England-Owen, C
    Zuech, N
    Pfaff, C
    Newhouse, J
    Bagiella, E
    Hetjan, D
    Sawczuk, I
    Benson, M
    Olsson, C
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 28 - 33
  • [8] Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer
    Sinibaldi, VJW
    Carducci, M
    Laufer, M
    Eisenberger, M
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 45 - 48
  • [9] Weekly docetaxel for advanced hormone-refractory prostate cancer
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V.
    Leonardi, V.
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII154 - VII154
  • [10] Significance of docetaxel in the chemotherapy of hormone-refractory prostate cancer
    Wolff, JM
    [J]. ONKOLOGIE, 2003, 26 : 37 - 40
12345